跳至主要内容
临床试验/EUCTR2006-002424-42-IT
EUCTR2006-002424-42-IT进行中(未招募)不适用

Evaluation of Safety and Efficacy on Visual Acuity Outcome and Choroidal Neovascularization of Intravitreal Somministration of Bevacizumab Avastin, Roche, United Kingdom in patients with Subfoveal Choroidal Neovascularization due to Age Related Macular Degeneration - ND

OSPEDALE SACRO CUORE-DON CALABRIA0 个研究点目标入组 150 人开始时间: 2006年6月5日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1.Patients with subfoveal CNV due to ARMD who did not respond to currently available treatments presenting enlargment of CNV, and or reduced VA 2. 1 50 VA 4 10 3. Patients with bilateral disease will receive the treatment only in one eye in order to evaluate the risks benefits. Only in case of benefit, the second eye will be treated.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1.Poor Blood Pressure control 2.Previous Thromboembolic events, myocardial infarction, cerebral stroke. 3.Pregnant women, or fertile age women who do not take the contraceptive pills 4.Breast feeding women

研究者

发起方
OSPEDALE SACRO CUORE-DON CALABRIA

相似试验